These outcomes, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two guidance the concept of targeting ACKR3 as a unique technique to modulate the opioid program, which could open up new therapeutic avenues for opioid-associated disorders. Disclaimer: The above mentioned is https://christopherp694kgd5.governor-wiki.com/user